Clinical Trial Update: Veliparib in Combination With Carboplatin And Weekly Paclitaxel in Japanese Subjects With Ovarian Cancer [Phase 1]

View source ↗

Summary

Phase 1 trial update evaluating Veliparib in combination with carboplatin and weekly paclitaxel in Japanese patients with ovarian cancer; the study has complete…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ovarian Cancer

Drugs mentioned

• CARBOPLATIN (Carboplatin)
• PACLITAXEL (PACLITAXEL)
• Veliparib (veliparib)

Snippet

Sponsor: AbbVie | Conditions: Ovarian Cancer | Phase 1 | Status: COMPLETED